MBX vs MPC · $1.98B cap vs P/E 16, rev $86.19B
MBX Biosciences, Inc. Common Stock (MBX) versus Marathon Petroleum Corp (MPC) — a side-by-side from cached financials, not a winner call.
MBX Biosciences, Inc. Common Stock (MBX) is a biotechnology company listed on NASDAQ.
Marathon Petroleum Corp (MPC) is a oil & gas refining & marketing company listed on US.
MBX does not have a complete income-statement cache yet.
Latest reported MPC revenue for 2026-06-30 was $86.19B. Net income was $5.65B. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
MBX currently screens at market cap $1.98B. MPC currently screens at market cap $71.41B and trailing P/E 16.1.
Not investment advice. Open the MBX and MPC stock pages for the full models.
Not investment advice.